Literature DB >> 11602004

Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

M V Vitiello1, S Borson.   

Abstract

Older adults represent an ever-growing proportion of the population of the industrialised nations, with a corresponding increase in the numbers of patients with dementing disorders. A common complaint in both normal aging and the dementias is that of significant sleep disturbance. The major causes of sleep disruption in aging and dementia include: (i) physiological changes that arise as part of normal, 'nonpathological' aging; (ii) sleep problems due to one of many physical or mental health conditions and their treatments; (iii) primary sleep disorders; (iv) poor 'sleep hygiene', that is, sleep-related practices and habits; and (v) some combination of these factors. Disrupted sleep in patients with dementia is a significant cause of stress for caregivers and frequently leads to institutionalisation of patients. It should be a target of clinical management when the goal is sustained home care, and when it is associated with disturbances of mood or behaviour. While the neuropathology of dementia can directly disrupt sleep, sleep disturbances in patients with dementia often have multiple causes that require systematic evaluation. Thorough assessment of associated psychopathology, day-time behaviour, medical disorders, medications, pain and environmental conditions is needed for optimal management. Differential diagnosis of a sleep problem in dementia is the basis of rational pharmacotherapy. However, patients with dementia are likely to be more sensitive than elderly persons without dementia to adverse cognitive and motor effects of drugs prescribed for sleep. Clinicians need to: (i) evaluate sleep outcomes when treating medical, psychiatric and behavioural disorders in older adults; (ii) be alert to emerging behavioural and environmental approaches to treatment; (iii) combine nonpharmacological strategies with drug therapies, when required, for added value; and (iv) avoid use of multiple psychotropic medications unless they prove essential to the adequate management of sleep disturbances.

Entities:  

Mesh:

Year:  2001        PMID: 11602004     DOI: 10.2165/00023210-200115100-00004

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  136 in total

Review 1.  Adapting living environments for persons with Alzheimer's disease.

Authors:  L A Grant; A R Sommers
Journal:  Geriatrics       Date:  1998-09

2.  Circadian rest-activity rhythm disturbances in Alzheimer's disease.

Authors:  E J van Someren; E E Hagebeuk; C Lijzenga; P Scheltens; S E de Rooij; C Jonker; A M Pot; M Mirmiran; D F Swaab
Journal:  Biol Psychiatry       Date:  1996-08-15       Impact factor: 13.382

Review 3.  Review and analysis of caregiver burden and nursing home placement.

Authors:  M C Chenier
Journal:  Geriatr Nurs       Date:  1997 May-Jun       Impact factor: 2.361

4.  Effects of physical therapy on functional status of nursing home residents.

Authors:  C D Mulrow; M B Gerety; D Kanten; L A DeNino; J E Cornell
Journal:  J Am Geriatr Soc       Date:  1993-03       Impact factor: 5.562

5.  THA does not affect sleep or EEG spectral power in Alzheimer's disease.

Authors:  D Petit; J Montplaisir; D Lorrain; S Gauthier
Journal:  Biol Psychiatry       Date:  1993-05-15       Impact factor: 13.382

6.  Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation.

Authors:  L D Burgio; K Scilley; J M Hardin; J Janosky; P Bonino; S C Slater; R Engberg
Journal:  J Gerontol       Date:  1994-09

7.  Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes.

Authors:  S Maggi; J A Langlois; N Minicuci; F Grigoletto; M Pavan; D J Foley; G Enzi
Journal:  J Am Geriatr Soc       Date:  1998-02       Impact factor: 5.562

8.  Delirium risk factors in elderly hospitalized patients.

Authors:  M Elie; M G Cole; F J Primeau; F Bellavance
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

9.  Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

Authors:  J S Street; W S Clark; K S Gannon; J L Cummings; F P Bymaster; R N Tamura; S J Mitan; D L Kadam; T M Sanger; P D Feldman; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-10

10.  Sleep-disordered breathing in community-dwelling elderly.

Authors:  S Ancoli-Israel; D F Kripke; M R Klauber; W J Mason; R Fell; O Kaplan
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

View more
  68 in total

1.  A sleep continuity scale in Alzheimer's disease: validation and relationship with cognitive and functional deterioration.

Authors:  R Manni; E Sinforiani; C Zucchella; M Terzaghi; C Rezzani
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

Review 2.  The management of sleep and circadian disturbance in patients with dementia.

Authors:  Qiuping Pearl Zhou; Lorena Jung; Kathy C Richards
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

3.  Characterizing sleep problems in persons with Alzheimer's disease and normal elderly.

Authors:  Rochelle E Tractenberg; Clifford M Singer; Jeffrey A Kaye
Journal:  J Sleep Res       Date:  2006-03       Impact factor: 3.981

4.  Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Authors:  Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-08       Impact factor: 2.959

5.  Strength training, walking, and social activity improve sleep in nursing home and assisted living residents: randomized controlled trial.

Authors:  Kathy C Richards; Corinne Lambert; Cornelia K Beck; Donald L Bliwise; William J Evans; Gurpreet K Kalra; Morton H Kleban; Rebecca Lorenz; Karen Rose; Nalaka S Gooneratne; Dennis H Sullivan
Journal:  J Am Geriatr Soc       Date:  2011-02       Impact factor: 5.562

Review 6.  Sleep disruption and quality of life in persons with dementia: A state-of-the-art review.

Authors:  Darina V Petrovsky; Miranda Varrasse McPhillips; Junxin Li; Ariana Brody; Laurel Caffeé; Nancy A Hodgson
Journal:  Geriatr Nurs       Date:  2018-05-24       Impact factor: 2.361

7.  Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.

Authors:  Ka Yi G Koo; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2019       Impact factor: 3.498

8.  Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type.

Authors:  Antonio Lobo; Raúl López-Antón; Concepción de-la-Cámara; Miguel Angel Quintanilla; Antonio Campayo; Pedro Saz
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Phenotyping apathy in individuals with Alzheimer disease using functional principal component analysis.

Authors:  Jamie M Zeitzer; Renaud David; Leah Friedman; Emmanuel Mulin; René Garcia; Jia Wang; Jerome A Yesavage; Philippe H Robert; William Shannon
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

10.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.

Authors:  Els I S Most; Philip Scheltens; Eus J W Van Someren
Journal:  Trials       Date:  2010-02-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.